Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Beam Therapeutics
Biotech
Prime wins gene editing patent fight with Beam
The quarrel stemmed from a 2019 agreement between the two biotechs, which both originated from research done at the Harvard lab of David Liu, Ph.D.
Darren Incorvaia
Jul 8, 2026 11:07am
Sanofi, Wave post updates in race to end AATD’s 40-year drought
May 18, 2026 4:30pm
Beam rejigs deal to retain technology amid partner's dissolution
Mar 6, 2026 8:20am
After gene therapy exit, Pfizer licenses Beam gene editing asset
Feb 25, 2026 9:43am
Inside Beam's 'big push' for in vivo gene editing
Jan 21, 2026 7:52am
Wave reports AATD win, but investors lukewarm
Sep 3, 2025 3:00pm
